Form4insider filings, from the source

SEC Form 4 · accession 0001140361-16-056904

BIOMARIN PHARMACEUTICAL INC · BMRN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Robert Baffi
Officer — EVP, Technical Operations
Period of report
Jan 7, 2016
Accepted (ET)
Mar 7, 2016 · 8:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jan 7, 2016G2,675$0.00D119,761D
Common StockJan 7, 2016G2,675$0.00A34,351IShares held by the Baffi Family Trust
Common StockF2Mar 3, 2016G45,727$0.00D74,034D
Common StockMar 3, 2016G45,727$0.00A80,078IShares held by the Baffi Family Trust
Common StockMar 3, 2016F2,395$89.57D71,639D
Common StockF3Mar 7, 2016G2,191$0.00D69,448D
Common StockMar 7, 2016G2,191$0.00A82,269IShares held by the Baffi Family Trust

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses